Many patients belonging to the frail group benefit from pharmacotherapy, although progression seems inevitable in pre frail patients treated with a-blockers. Surgical management of those patients has high rates of failure. That’s the reason why a more conservative approach is adopted for those patients.
Written by: Themistoklis Ch Bellos, Lazaros I. Tzelves, Ioannis S. Manolitsis, Stamatios N. Katsimperis, Marinos V. Berdempes, Andreas Skolarikos, Nikolaos D. Karakousis
2nd Department of Urology, Sismanoglio General Hospital of Athens, Athens.
Read the Abstract